Literature DB >> 28302395

Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.

Kelsey A Ludwig1, Amy E Pinkham2, Philip D Harvey3, Skylar Kelsven4, David L Penn5.   

Abstract

Social cognition is an important outcome in schizophrenia research. Unfortunately, there has been a lack of consensus regarding which measures of social cognition best capture this domain of functioning. The Social Cognition Psychometric Evaluation (SCOPE) study was developed to address the need for a battery of measures that have sound psychometric properties and can be implemented in clinical trials for individuals with chronic schizophrenia. The current study expands upon the SCOPE study by examining the psychometric properties of the eight candidate measures administered to individuals early in the course of psychosis. Thirty-eight stable outpatients with first episode psychosis and thirty-nine healthy controls completed the battery at baseline and one-month follow-up assessments. The SCOPE battery was evaluated on a collection of psychometric properties, including: (1) Reliability - including test-retest and internal consistency, (2) Between group differences, (3) Utility as a repeated measure, (4) Relationship to social and occupational functioning, (5) Incremental validity - variance in functioning beyond neurocognition, and (6) Feasibility - including practicality of administration and tolerability. Social cognition accounted for substantially more variance in functional outcome than neurocognition. Only one measure, the Hinting task, displayed adequate psychometric properties to be recommended for use in clinical research with first episode psychosis. The remaining candidate measures would require modifications before implementation or cannot be recommended for use in clinical research with first episode psychosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  First episode psychosis; Measurement; Psychometric evaluation; Schizophrenia; Social cognition

Mesh:

Year:  2017        PMID: 28302395      PMCID: PMC5735418          DOI: 10.1016/j.schres.2017.03.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  46 in total

1.  Test-retest stability of neuropsychological testing and individual differences in variability in schizophrenia outpatients.

Authors:  Tamsine Conway Greig; Sarah S Nicholls; Bruce E Wexler; Morris D Bell
Journal:  Psychiatry Res       Date:  2004-12-30       Impact factor: 3.222

2.  Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ).

Authors:  Benjamin Buck; Colin Iwanski; Kristin M Healey; Michael F Green; William P Horan; Robert S Kern; Junghee Lee; Stephen R Marder; Steve P Reise; David L Penn
Journal:  J Psychiatr Res       Date:  2017-01-09       Impact factor: 4.791

Review 3.  The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

Authors:  Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam
Journal:  Neurosci Biobehav Rev       Date:  2010-07-08       Impact factor: 8.989

Review 4.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

5.  Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Authors:  Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2006-04-19       Impact factor: 7.853

6.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

7.  Social skills performance assessment among older patients with schizophrenia.

Authors:  T L Patterson; S Moscona; C L McKibbin; K Davidson; D V Jeste
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

8.  Facial emotion recognition in schizophrenia: intensity effects and error pattern.

Authors:  Christian G Kohler; Travis H Turner; Warren B Bilker; Colleen M Brensinger; Steven J Siegel; Stephen J Kanes; Raquel E Gur; Ruben C Gur
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

Review 9.  Facial emotion identification in early-onset and first-episode psychosis: a systematic review with meta-analysis.

Authors:  Sophie J Barkl; Suncica Lah; Anthony W F Harris; Leanne M Williams
Journal:  Schizophr Res       Date:  2014-08-30       Impact factor: 4.939

Review 10.  Social cognition.

Authors:  Chris D Frith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-12       Impact factor: 6.237

View more
  10 in total

1.  Self-assessment of social cognitive ability in schizophrenia: Association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes.

Authors:  Juliet M Silberstein; Amy E Pinkham; David L Penn; Philip D Harvey
Journal:  Schizophr Res       Date:  2018-04-17       Impact factor: 4.939

2.  Social cognition, neurocognition, symptomatology, functional competences and outcomes in people with schizophrenia - A network analysis perspective.

Authors:  Michal Hajdúk; David L Penn; Philip D Harvey; Amy E Pinkham
Journal:  J Psychiatr Res       Date:  2021-09-24       Impact factor: 4.791

3.  Social Cognition Psychometric Evaluation: Results of the Final Validation Study.

Authors:  Amy E Pinkham; Philip D Harvey; David L Penn
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  Functional Impairments and Theory of Mind Deficits in Schizophrenia: A Meta-analysis of the Associations.

Authors:  Élisabeth Thibaudeau; Caroline Cellard; Mélissa Turcotte; Amélie M Achim
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

5.  Social cognition in schizophrenia.

Authors:  Nare Torosyan; Robert G Bota
Journal:  Ment Illn       Date:  2017-10-19

6.  Measuring mentalizing: A comparison of scoring methods for the hinting task.

Authors:  Hans S Klein; Cassi R Springfield; Emily Bass; Kelsey Ludwig; David L Penn; Philip D Harvey; Amy E Pinkham
Journal:  Int J Methods Psychiatr Res       Date:  2020-05-09       Impact factor: 4.035

7.  Co-occurring Deficits in Clinical and Cognitive Insight in Prolonged Schizophrenia-Spectrum Disorders: Relationship to Metacognitive Deficits.

Authors:  Joshua E Mervis; Kelsey A Bonfils; Samuel E Cooper; Courtney Wiesepape; Paul H Lysaker
Journal:  Schizophr Bull Open       Date:  2021-07-20

8.  Development of an Ecologically Valid Assessment for Social Cognition Based on Real Interaction: Preliminary Results.

Authors:  Guillermo Benito-Ruiz; Cristina Luzón-Collado; Javier Arrillaga-González; Guillermo Lahera
Journal:  Behav Sci (Basel)       Date:  2022-02-18

9.  Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition.

Authors:  Verónica Romero-Ferreiro; Lorena García-Fernández; Ana Isabel Aparicio; Isabel Martínez-Gras; Mónica Dompablo; Luis Sánchez-Pastor; David Rentero; Miguel Ángel Alvarez-Mon; Juan Manuel Espejo-Saavedra; Guillermo Lahera; Paloma Marí-Beffa; José Luis Santos; Roberto Rodriguez-Jimenez
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

10.  Examining the association of life course neurocognitive ability with real-world functioning in schizophrenia-spectrum disorders.

Authors:  Sylvia Romanowska; Michael W Best; Christopher R Bowie; Colin A Depp; Thomas L Patterson; David L Penn; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2022-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.